What the business is, and whether it's a good one at a fair price.
A Healthcare Equipment & Supplies company listed on BSE, reporting revenue of ₹49 Cr over the trailing twelve months.
Measured from the filed financials, judged against its Medical Equipment & Supplies peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from CHOKSI ASIA LIMITED's filed financials and exchange disclosures
CHOKSI ASIA LIMITED is a Healthcare Equipment & Supplies company listed on BSE.
Yes. Over the trailing twelve months CHOKSI ASIA LIMITED reported a net profit of ₹5 Cr on revenue of ₹49 Cr.
Not in the latest reported year — CHOKSI ASIA LIMITED's dividend payout for FY26 was nil.
Effectively yes. It holds ₹5 Cr more cash than debt. Debt stands at 0.05× equity.
On trailing P/E, CHOKSI ASIA LIMITED ranks 10 of 17 in Medical Equipment & Supplies — cheaper than 44% of them, against an industry median of 20.0×. This is a position, not a valuation judgement.
On a typical session CHOKSI ASIA LIMITED moves 2.64% — that is the median absolute close-to-close move across its last 267 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by CHOKSI ASIA LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
